ClinicalTrials.govpublic full text
Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy.
prostate adenocarcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 908960
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.